Satellos Bioscience Inc. (MSLE) stock
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.63−0.21 (-3.00%)
Close on Nov 13, 2026Market cap $102.42MP/E –Yield –
Satellos Bioscience cash
Cash and short-term investments held at the end of each period.
Satellos Bioscience's cash was $9.80M at Dec 31, 2025. For fiscal 2025 it was $9.80M, down 75.5% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.80M | -75.5% |
| FY2024 | Dec 31, 2024 | $40.07M | +140.2% |
| FY2023 | Dec 31, 2023 | $16.68M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $9.80M | – |
| Q4 FY2024 | Dec 31, 2024 | $40.07M | – |
| Q4 FY2023 | Dec 31, 2023 | $16.68M | – |
See a number that looks wrong?